CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2017		$ 384,943	$ (246)	$ (159,435)	$ 225,262
Balance at beginning of period (in shares) at Dec. 31, 2017	30,856,505
Increase (Decrease) in Stockholders' Equity
Exercise of stock options and vesting of RSUs		378			378
Exercise of stock options and vesting of RSUs, shares	49,124
Unrealized gain on marketable securities			(65)		(65)
Foreign currency translation adjustment			(17)		(17)
Stock-based compensation expense		5,143			5,143
Net loss				(30,229)	(30,229)
Balance at end of period at Mar. 31, 2018		390,464	(328)	(189,664)	200,472
Balance at end of period (in shares) at Mar. 31, 2018	30,905,629
Balance at beginning of period at Dec. 31, 2018		507,366	(69)	(292,173)	$ 215,124
Balance at beginning of period (in shares) at Dec. 31, 2018	41,210,725				41,210,725
Increase (Decrease) in Stockholders' Equity
Exercise of stock options and vesting of RSUs		(188)			$ (188)
Exercise of stock options and vesting of RSUs, shares	58,918
Unrealized gain on marketable securities			34		34
Foreign currency translation adjustment			(14)		(14)
Stock-based compensation expense		4,862			4,862
Net loss				(37,565)	(37,565)
Balance at end of period at Mar. 31, 2019		$ 512,040	$ (49)	$ (329,738)	$ 182,253
Balance at end of period (in shares) at Mar. 31, 2019	41,269,643				41,269,643